SCHEMBL7607003

SCHEMBL7607003

NC(=NO)c1cccnc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.55
PRKCI P41743 2/20 0.45
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
AKT1 P31749 1/20 0.39
BTK Q06187 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
PARP1 P09874 1/20 0.38
BACE1 P56817 2/20 0.36
SHMT2 P34897 1/20 0.36
RRM1 P23921 1/20 0.36
RRM2 P31350 1/20 0.36
RRM2B Q7LG56 1/20 0.36
CISD1 Q9NZ45 1/20 0.36
KDM4E B2RXH2 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29454980 1.00 NAPRT (0.55) NAPRTPRKCINOS3NOS1NOS2
SCHEMBL20587560 0.80 L3MBTL1 (0.42) NAPRTL3MBTL1LMNAGAAPARP1
SCHEMBL31171605 0.78 NAPRT (0.53) NAPRTPRKCINOS3NOS1NOS2
SCHEMBL22559509 0.78 NAPRT (0.53) NAPRTPRKCINOS3NOS1NOS2
SCHEMBL30867623 0.78 NAPRT (0.53) NAPRTPRKCINOS3NOS1NOS2
SCHEMBL3461723 0.78 P2RX7 (0.51) NAPRTNOS3NOS1NOS2L3MBTL1
SCHEMBL17737963 0.78 LMNA (0.53) L3MBTL1LMNAGAAALDH1A1TDP1
SCHEMBL6599458 0.78 LMNA (0.53) L3MBTL1LMNAGAAALDH1A1TDP1
SCHEMBL6599460 0.78 LMNA (0.53) L3MBTL1LMNAGAAALDH1A1TDP1
SCHEMBL3461720 0.78 P2RX7 (0.51) NAPRTNOS3NOS1NOS2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012074718-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS ALLERGAN, INC. (US) 2012-06-07 WO disclosed
US-8183264-B2 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same Eisai R&D Managment Co., Ltd. (JP) 2012-05-22 US disclosed
US-20100099718-A1 PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROARYL RING, AND ANTIFUNGAL AGENT COMPRISING THE SAME EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099718-A1 PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROARYL RING, AND ANTIFUNGAL AGENT COMPRISING THE SAME ERG28, CBR3, CBR1 NAPRT 1563/4885PRKCI 3956/4885NOS3 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.